Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | -2.05% |
|
-2.62% | -66.48% |
06-10 | Top Premarket Decliners | MT |
06-07 | BioCardia Receives Patent for Transendocardial Biotherapeutic Delivery Catheter; Shares Rise Pre-Bell | MT |
Business Summary
Number of employees: 18
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -64.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -64.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Altman
CEO | Chief Executive Officer | 57 | 01-12-31 |
David McClung
DFI | Director of Finance/CFO | 61 | 13-08-31 |
Chief Tech/Sci/R&D Officer | - | 17-07-31 | |
Sujith Shetty
CTO | Chief Tech/Sci/R&D Officer | - | 19-02-28 |
Ian McNiece
CTO | Chief Tech/Sci/R&D Officer | 70 | 17-11-07 |
Anne Laluc
IRO | Public Communications Contact | - | - |
Mark Schwartz
PRN | Corporate Officer/Principal | - | 18-10-31 |
Edward Gillis
PRN | Corporate Officer/Principal | 62 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Stertzer
BRD | Director/Board Member | 88 | 01-12-31 |
Jay Moyes
BRD | Director/Board Member | 70 | 10-12-31 |
Richard Krasno
BRD | Director/Board Member | 82 | 16-10-23 |
Director/Board Member | 53 | 23-10-17 | |
Peter Altman
CEO | Chief Executive Officer | 57 | 01-12-31 |
Andrew Blank
CHM | Chairman | 68 | 19-09-30 |
Jim Allen
BRD | Director/Board Member | 69 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,820,274 | 1,283,689 ( 70.52 %) | 0 | 70.52 % |
Company contact information
![address BioCardia, Inc.(BCDA)](https://cdn.zonebourse.com/static/address/64302330.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-66.48% | 6.1M | |
+16.42% | 122B | |
+19.02% | 113B | |
+2.65% | 22.66B | |
-11.63% | 16.68B | |
-16.29% | 16.61B | |
-39.57% | 16.92B | |
+2.68% | 13.62B | |
+21.16% | 11.04B | |
+108.78% | 10.43B |
- Stock Market
- Equities
- BCDA Stock
- Company BioCardia, Inc.